Meniscus Allograft versus Autograft Transplantation

To know basics about Meniscus transplantation

1. Concept & Tissue Source

2. Indications & Patient Selection

Meniscal Allograft

• Symptomatic meniscal deficiency after subtotal/total meniscectomy.
• Young / middle-aged, stable, well-aligned knees with no or mild chondral damage. Orthopedic Reviews+1
• Often combined with ACL reconstruction, HTO, or cartilage procedures in “biologic knee preservation” packages. Orthopedic Reviews

Tendon Autograft (ST / PL)

• Same basic indications: symptomatic post-meniscectomy knee in young patients.
• Particularly attractive where allograft is:
  • Unavailable / legally restricted / prohibitively expensive. PMC+2PubMed+2
• Some techniques used for segmental reconstruction rather than whole-meniscus replacement. PubMed+1

Contraindications (advanced OA, malalignment not corrected, unaddressed instability) are broadly similar for both.

3. Surgical Technique & Sizing

4. Biomechanics

Allograft

• Multiple cadaveric studies show MAT can restore contact area and reduce peak contact pressures close to native meniscus, though extrusion and subtle kinematic changes remain issues. ScienceDirect+1

Semitendinosus / Peroneus Longus Autograft

• Doubled semitendinosus autograft lateral “meniscus” significantly improved tibio-femoral contact mechanics and kinematics compared with meniscectomy, approaching native values. PMC
• Preclinical and early human data suggest tendon autografts can remodel and function as a load-sharing structure, but long-term chondroprotection is still unproven. PMC+2PMC+2

5. Clinical Outcomes & Survivorship

Allograft MAT

• Systematic reviews and case series show significant improvement in pain and function (KOOS, IKDC, Lysholm) with 10–15-year graft survival rates ~70–85% depending on definition of failure and cartilage status. Orthopedic Reviews+2Dr. Brian J. Cole+2
• Age ≥40 is not an absolute contraindication; PRO improvement comparable to younger patients if cartilage is reasonably preserved. Dr. Brian J. Cole

Autograft (ST/PL)

• Rönnblad et al: pilot series of semitendinosus “neomeniscus” showed improvement in post-meniscectomy symptoms and function at mid-term, suggesting ST can act as a meniscal substitute. PMC
• Seitz et al: biomechanical study supports restoration of contact mechanics with ST lateral graft. PMC
• Case reports and small series (ST and PL for medial and lateral replacement) report good short-term pain relief and functional gains, but follow-up is usually ≤2 years. PubMed+4PMC+4PubMed+4
• A recent 2-year prospective comparative study (autograft vs allograft) reported better pain relief and quality of life with autografts (semitendinosus or patellar tendon) than with MAT, but with similar activity levels; authors emphasise need for longer follow-up. Esska Journals+2ResearchGate+2

So right now, MAT has stronger long-term evidence, while tendon autograft has promising short-term data but is still “under evaluation”.

6. Risks, Complications & Donor Site Morbidity

Meniscal Allograft

• Risks: graft extrusion, tearing, shrinkage, failure; re-operation and conversion to arthroplasty are not rare in high-risk cartilage. Orthopedic Reviews+2Dr. Brian J. Cole+2
• Theoretical risks of disease transmission and immune response, although modern tissue banking makes this very low. ScienceDirect
• No donor site morbidity.

Semitendinosus / Peroneus Longus Autograft

• Avoids immunologic and infectious risks of allograft and regulatory hassles of tissue banking. PMC+1
• Donor-site issues:
  • ST harvest is familiar from ACL, usually minimal long-term deficit.
  • PL harvest: ACL literature suggests good knee function without major ankle weakness, but careful selection is needed for high-demand ankle athletes. jccpractice.com+3Nature+3ijoro.org+3
• Long-term behaviour of the neomeniscus (degeneration, creep, extrusion) is unknown; all current enthusiasm is based on early results.

7. Availability, Regulation & Cost

• Allograft:
  • Requires accredited tissue bank; in India this can be the rate-limiting step, with added costs and paperwork.
  • Cost per graft is significant. ScienceDirect+1
• Autograft (ST/PL):
  • Always available; no dependence on graft bank or import.
  • Lower direct cost; theatre time and fixation implants are the major expense.
  • Several authors specifically propose tendon autograft as a solution where MAT is “restricted by availability, legal issues and high cost.” Jisakos+4PMC+4PubMed+4

My Take (for your practice / website positioning)

If I had to summarise in one line for surgeons:

MAT remains the gold standard for biologic meniscal replacement because of its long-term data, but semitendinosus/peroneus-longus autograft “neomeniscus” is an exciting, lower-cost, immunologically safer alternative that is still in its evidence-building phase.

For India-type settings, your honest messaging could be:

• MAT where good tissue banking and funding exist, particularly in compliant, well-counselled young patients.
• Autograft reconstruction as a reasonable option in highly selected young, symptomatic post-meniscectomy knees where allograft is not accessible or cost-effective and preferably within a prospective study / registry.

Key References (you can drop into a paper / slide)

1. Peters G, Smillie I. The current state of meniscal allograft transplantation and replacement. Knee. 2002. ScienceDirect
2. Orthopedic Reviews – Meniscal allograft transplantation combined with ACL reconstruction: a systematic review. 2023. Orthopedic Reviews
3. Frank RM et al. Do outcomes of meniscal allograft transplantation differ based on age and sex? 2022. Dr. Brian J. Cole
4. Wei G et al. Comparison of medial versus lateral meniscus allograft transplantation. 2016. PMC
5. Rönnblad E et al. Autologous semitendinosus tendon graft could function as a meniscal transplant after total or subtotal meniscectomy. KSSTA. 2022. PMC
6. Seitz AM et al. Autologous semitendinosus meniscus graft significantly improves knee joint kinematics and contact mechanics. 2023. PMC
7. Milenin O et al. Lateral meniscus replacement using peroneus longus autograft. Arthrosc Tech. 2020. PMC
8. Kim Y et al. The potential of tendon autograft as meniscus substitution. JISAKOS. 2024. Jisakos
9. Dong J et al. / Chi PC et al. Comparative review: allograft versus autologous tendon transplantation for meniscus reconstruction. 2024–25. Lippincott Journals+1